Recent Advances in Nanosuspension Technology for Drug Delivery

被引:24
作者
Arora, Daisy [1 ,2 ]
Khurana, Bharat [1 ,3 ]
Rath, Goutam [1 ]
Nanda, Sanju [2 ]
Goyal, Amit K. [1 ,4 ]
机构
[1] ISF Coll Pharm, Dept Pharmaceut, Nanomed Res Ctr, Moga, Punjab, India
[2] Maharshi Dayanand Univ, Dept Pharmaceut Sci, Rohtak, Haryana, India
[3] Maharaja Ranjit Singh Punjab Tech Univ, Dept Pharm, Bathinda, Punjab, India
[4] Gujarat Forens Sci Univ, Inst Res & Dev, Gandhinagar, India
关键词
Nanosuspension; solubility; bioavailability; stabilizers; media milling; high pressure homogenization; POORLY SOLUBLE DRUGS; HIGH-PRESSURE HOMOGENIZATION; PARTICLE-SIZE REDUCTION; IN-VIVO EVALUATION; ORAL BIOAVAILABILITY; ITRACONAZOLE NANOSUSPENSION; PACLITAXEL NANOSUSPENSION; FORMULATION OPTIMIZATION; EUDRAGIT RS100(R); TOPICAL DELIVERY;
D O I
10.2174/1381612824666180522100251
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Discovery and development of BCS class 1 drugs through high throughput screening is one of the biggest challenge faced by formulation scientist. Methods: There are a number of approaches that have been exploited to enhance the solubility and permeability of drugs. Among them, development of nanosuspension has offered several benefits. These techniques may increase effective surface area due to nanonization of drug particles and further increases saturation solubility and dissolution properties for improved bioavailability. Various development methods are patented which are cost effective and easy to scale up. Conclusion: Several unique features of nanosuspension make it a versatile delivery system for different routes of administration including oral, dermal, ocular, parenteral and pulmonary. The present review is focused on preparatory techniques and formulation considerations of nanosuspension. Brief information about evaluation parameters, applications of nanosuspension in drug delivery and patented and marketed products available is also discussed.
引用
收藏
页码:2403 / 2415
页数:13
相关论文
共 93 条
[1]   Nanosuspension Technology For Poorly Soluble Drugs: Recent Researches, Advances and Patents [J].
Agarwal, Vijay ;
Bajpai, Meenakshi .
RECENT PATENTS ON NANOTECHNOLOGY, 2015, 9 (03) :178-194
[2]   Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation [J].
Allam, Ahmed N. ;
Hamdallah, Herif I. ;
Abdallah, Ossama Y. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 12 :4733-4745
[3]  
Angus D, 2011, EP, Patent No. [2386292 A1, 2386292A1]
[4]  
[Anonymous], 1981, TECHNIQUES SOLUBILIZ
[5]   Nanosuspension technology and its applications in drug delivery [J].
Arunkumar, N. ;
Deecaraman, M. ;
Rani, C. .
ASIAN JOURNAL OF PHARMACEUTICS, 2009, 3 (03) :168-173
[6]  
Becker R., 1999, Pharmaceutical nanosuspensions formedicament administration as systems with in-creased saturation solubility and rate of solution, Patent No. [US 5858410 A, 5858410A]
[7]   Particle size effect of curcumin nanosuspensions on cytotoxicity, cellular internalization, in vivo pharmacokinetics and biodistribution [J].
Bi, Chao ;
Miao, Xiao Qing ;
Chow, Sing Fung ;
Wu, Wen Jin ;
Yan, Ru ;
Liao, Y. H. ;
Chow, Albert Hee-Lum ;
Zheng, Ying .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (03) :943-953
[8]   Enhanced ocular anti-inflammatory activity of lbuprofen carried by an Eudragit RS100® nanoparticle suspension [J].
Bucolo, C ;
Maltese, A ;
Puglisi, G ;
Pignatello, R .
OPHTHALMIC RESEARCH, 2002, 34 (05) :319-323
[9]  
Chandiran SI, 2014, INT J BIOPHARM, V5, P214
[10]  
Chang D, 2017, ARTIF CELL NANOMED B, P1